BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35464826)

  • 21. Hypoxia-inducible factor-1α and nuclear factor-κB play important roles in regulating programmed cell death ligand 1 expression by epidermal growth factor receptor mutants in non-small-cell lung cancer cells.
    Guo R; Li Y; Wang Z; Bai H; Duan J; Wang S; Wang L; Wang J
    Cancer Sci; 2019 May; 110(5):1665-1675. PubMed ID: 30844110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter.
    Ramanathan M; Pinhal-Enfield G; Hao I; Leibovich SJ
    Mol Biol Cell; 2007 Jan; 18(1):14-23. PubMed ID: 17065555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential regulation of HIF-1alpha isoforms in murine macrophages by TLR4 and adenosine A(2A) receptor agonists.
    Ramanathan M; Luo W; Csóka B; Haskó G; Lukashev D; Sitkovsky MV; Leibovich SJ
    J Leukoc Biol; 2009 Sep; 86(3):681-9. PubMed ID: 19477908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemoglobin-induced endothelial cell permeability is controlled, in part, via a myeloid differentiation primary response gene-88-dependent signaling mechanism.
    Lisk C; Kominsky D; Ehrentraut S; Bonaventura J; Nuss R; Hassell K; Nozik-Grayck E; Irwin DC
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):619-26. PubMed ID: 23713977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory stimulation and hypoxia cooperatively activate HIF-1{alpha} in bronchial epithelial cells: involvement of PI3K and NF-{kappa}B.
    Jiang H; Zhu YS; Xu H; Sun Y; Li QF
    Am J Physiol Lung Cell Mol Physiol; 2010 May; 298(5):L660-9. PubMed ID: 20139176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha.
    Rius J; Guma M; Schachtrup C; Akassoglou K; Zinkernagel AS; Nizet V; Johnson RS; Haddad GG; Karin M
    Nature; 2008 Jun; 453(7196):807-11. PubMed ID: 18432192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
    Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
    Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of 11β-HSD1 expression during adipose tissue expansion by hypoxia through different activities of NF-κB and HIF-1α.
    Lee JH; Gao Z; Ye J
    Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1035-41. PubMed ID: 23512810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SNAIL gene inhibited by hypoxia-inducible factor 1α (HIF-1α) in epithelial ovarian cancer.
    Zhang P; Liu Y; Feng Y; Gao S
    Int J Immunopathol Pharmacol; 2016 Sep; 29(3):364-75. PubMed ID: 27044634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Correlation between bacterial L-form infection, expression of HIF-1α/MMP-9 and vasculogenic mimicry in epithelial ovarian cancer].
    Yu L; Wu SW; Zhou L; Song WQ
    Sheng Li Xue Bao; 2012 Dec; 64(6):657-65. PubMed ID: 23258329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
    Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
    Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PRL-3 promotes gastric cancer migration and invasion through a NF-κB-HIF-1α-miR-210 axis.
    Zhang C; Tian W; Meng L; Qu L; Shou C
    J Mol Med (Berl); 2016 Apr; 94(4):401-15. PubMed ID: 26548949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of hypoxia-inducible factor-1alpha by NF-kappaB.
    van Uden P; Kenneth NS; Rocha S
    Biochem J; 2008 Jun; 412(3):477-84. PubMed ID: 18393939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α.
    Remels AH; Gosker HR; Verhees KJ; Langen RC; Schols AM
    Endocrinology; 2015 May; 156(5):1770-81. PubMed ID: 25710281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB.
    Frede S; Stockmann C; Freitag P; Fandrey J
    Biochem J; 2006 Jun; 396(3):517-27. PubMed ID: 16533170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NF-κB suppresses HIF-1α response by competing for P300 binding.
    Mendonça DB; Mendonça G; Aragão FJ; Cooper LF
    Biochem Biophys Res Commun; 2011 Jan; 404(4):997-1003. PubMed ID: 21187066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A reduced level of the long non-coding RNA SNHG8 activates the NF-kappaB pathway by releasing functional HIF-1alpha in a hypoxic inflammatory microenvironment.
    Wang C; Yang Q; Han Y; Liu H; Wang Y; Huang Y; Zheng Y; Li W
    Stem Cell Res Ther; 2022 Jun; 13(1):229. PubMed ID: 35659362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer.
    Ji F; Wang Y; Qiu L; Li S; Zhu J; Liang Z; Wan Y; Di W
    Int J Oncol; 2013 May; 42(5):1578-88. PubMed ID: 23545606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HAF drives the switch of HIF-1α to HIF-2α by activating the NF-κB pathway, leading to malignant behavior of T24 bladder cancer cells.
    Guan Z; Ding C; Du Y; Zhang K; Zhu JN; Zhang T; He D; Xu S; Wang X; Fan J
    Int J Oncol; 2014 Feb; 44(2):393-402. PubMed ID: 24316875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins.
    Li Z; Block MS; Vierkant RA; Fogarty ZC; Winham SJ; Visscher DW; Kalli KR; Wang C; Goode EL
    Tumour Biol; 2016 Oct; 37(10):13279-13286. PubMed ID: 27460076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.